You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-ADAM17 antibody - Activation site (ab39163)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab39163? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab39163 has been referenced in 6 publications.

  1. Takaguri A et al. A disintegrin and metalloprotease 17 mediates neointimal hyperplasia in vasculature. Hypertension 57:841-5 (2011). IHC-P; Rat. PubMed: 21357274
  2. Restituito S et al. Synaptic autoregulation by metalloproteases and gamma-secretase. J Neurosci 31:12083-93 (2011). WB, ICC/IF. PubMed: 21865451
  3. Chen YJ & Chang LS Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2. J Cell Physiol : (2011). PubMed: 21809341
  4. Liu WH & Chang LS Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanism. J Biol Chem 285:30506-15 (2010). WB; Human. PubMed: 20679348
  5. Liu WH et al. Taiwan cobra phospholipase A2 elicits posttranscriptional up-regulation of ADAM17 in human neuroblastoma SK-N-SH cells. J Cell Biochem 111:148-57 (2010). PubMed: 20506406
  6. Kwak HI et al. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices. Matrix Biol 28:470-9 (2009). PubMed: 19666115

Publishing research using ab39163? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"